NXLLF yields 200.00% · PFE yields 6.13%● Live data
📍 NXLLF pulled ahead of the other in Year 1
Combined, NXLLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NXLLF + PFE for your $10,000?
Nuix Limited provides investigative analytics and intelligence software solutions in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. The company offers Nuix Workstation, a solution for processing file formats and source types into meaningful information by capturing the content, metadata, and context; Nuix Discover that provides processing, analytics, and machine learning-powered review in a single platform; and Nuix Investigate, a solution which extracts, correlates, and contextualizes various types of data types, across people, objects, locations, and events. The company also provides Nuix Adaptive Security, monitors, detects, and responds to the threats of enterprises; Nuix Enterprise Collection Center, a solution to collect disk images or selected data from laptops, desktops, servers, enterprise file shares, and Microsoft sharepoint sites to legal, investigation, security, and compliance teams for investigation; Nuix Automation, a web-based multi-user graphical tool that allows to map out complex data processes across various activities and machines; and Nuix NLP, a solution which combines machine learning technologies with a proprietary language model to discover, understand, classify, and quantify text content. It serves corporations, governments, law enforcement industries, law firms, advisories, and service partners. The company was formerly known as Nuix Pty Ltd and changed its name to Nuix Limited in September 2020. Nuix Limited was founded in 2000 and is headquartered in Sydney, Australia.
Full NXLLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.